TO SET ADMINISTRATION FEES UNDER THE ARKANSAS MEDICAID PROGRAM FOR IMMUNIZATIONS AND MONOCLONAL ANTIBODIES FOR RESPIRATORY SYNCYTIAL VIRUS DISEASE; AND TO PROVIDE CIVIL IMMUNITY.

House Bill 1619 establishes administration fees under the Arkansas Medicaid Program for immunizations and monoclonal antibodies that protect infants and toddlers from Respiratory Syncytial Virus (RSV) disease. It mandates Medicaid to reimburse providers at a rate equal to 100% of the state's Vaccines for Children Program maximum administration fee for these specific treatments. Additionally, the bill grants civil immunity to individuals and entities involved in prescribing or administering these RSV protections to eligible patients. This immunity does not apply to actions that are grossly negligent, reckless, willful, or not performed with good faith and reasonable care.